CELEX: 
Language: en
Date: 2019-11-22
Title: COMMISSION DELEGATED REGULATION (EU) …/... amending Annex I to Regulation (EU) 2019/1021 of the European Parliament and of the Council as regards the listing of dicofol

EXPLANATORY MEMORANDUM
            
            
               1.CONTEXT OF THE DELEGATED ACT
            
            
               Article 1 of Regulation (EU) 2019/1021 establishes as the objective of that Regulation to protect human health and the environment from Persistent Organic Pollutants (‘POPs’) by prohibiting, phasing out as soon as possible, or restricting the manufacturing, placing on the market and use of substances subject to the Stockholm Convention on POPs. At the ninth Conference of the Parties to the Stockholm Convention, which took place in Geneva, Switzerland, from 29 April to 10 May 2019, the decision was taken to include dicofol in Annex A to the Convention (decision SC-9/11). The European Union supported that decision on the basis of Council Decision (EU) 2019/639. Pursuant to Article 15 of Regulation (EU) 2019/1021, the regulatory decision should be reflected in Annex I to Regulation (EU) 2019/1021 by adopting a separate delegated act to that effect. 
            
            
               The authorisations of plant protection products containing dicofol in the EU Member States had to be withdrawn by 30 March 2009 and any marketing and use of them had to expire by 30 March 2010 at the latest according to Commission Decision 2008/764/EC. In addition, there are no approved uses according to the Biocidal Products Regulation (EU) 528/2012.
            
            
            
               2.CONSULTATIONS PRIOR TO THE ADOPTION OF THE ACT
            
            
               The draft amendment was consulted with an expert group (the 'POP CA meeting') on [insert date] and comments were taken into account. The group is composed of all the relevant stakeholders - representatives of Member States, of the European Chemicals Agency, the chemicals industry and the civil society.
            
            
               A public consultation was carried out for the draft act from [insert date] to [insert date] [summarise comments received and replies] 
            
            
               3.LEGAL ELEMENTS OF THE DELEGATED ACT
            
            
               The delegated act amends the list of chemicals in Annex I on the basis of developments under the Convention, as required by Article 15(1) of Regulation (EU) 2019/1021. 
            
            
               COMMISSION DELEGATED REGULATION (EU) …/...
            
            
               of XXX
            
            
               amending Annex I to Regulation (EU) 2019/1021 of the European Parliament and of the Council as regards the listing of dicofol
            
            
               (Text with EEA relevance)
            
            
               THE EUROPEAN COMMISSION,
            
            
               Having regard to the Treaty on the Functioning of the European Union,
            
            
               Having regard to Regulation (EU) 2019/1021 of the European Parliament and of the Council of 20 June 2019 on persistent organic pollutants 
                  1
               , and in particular Article 15 (1) thereof,
            
            
               Whereas:
            
            
               (1)Regulation (EU) 2019/1021 implements the commitments of the Union under the Stockholm Convention on Persistent Organic Pollutants 
                  2
                (‘the Convention’) and under the Protocol to the 1979 Convention on Long-Range Transboundary Air Pollution on Persistent Organic Pollutants 
                  3
                (‘the Protocol’).
            
         
         
            
               (2)Annex A to the Convention (‘Elimination’) contains a list of chemicals for which each Party to the Convention is required to prohibit and/or take the legal and administrative measures necessary to eliminate their production, use, import and export.
            
            
               (3)The Conference of the Parties to the Convention has, pursuant to Article 8(9) of the Convention, decided in its ninth meeting to amend Annex A to the Convention in order to include dicofol in that Annex with no exemptions.
            
            
               (4)Part A of Annex I to Regulation (EU) 2019/1021, which contains a list of the substances listed in the Convention and in the Protocol as well as substances listed only in the Convention, should therefore be amended to include dicofol.
            
            
               (5)Regulation (EU) 2019/1021 should therefore be amended accordingly,
            
            
               HAS ADOPTED THIS REGULATION:
            
            
               Article 1
            
            
               Annex I to Regulation (EU) 2019/1021 is amended in accordance with the Annex to this Regulation.
            
            
               Article 2
            
            
               This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
            
            
               This Regulation shall be binding in its entirety and directly applicable in all Member States.
            
            
               Done at Brussels,
            
            
               
                     For the Commission
               
               
                     The President
                     […]
                     
                  
            
         
         
      
    ---documentbreak--- 
      
         
         
            
               EN
            
            
               ANNEX 
            
            
               In Part A of Annex I to Regulation (EU) 2019/1021, the following entry is added:
            
            
            
            
                     
                        Substance
                     
                  
                  
                     
                        CAS No
                     
                  
                  
                     
                        EC No
                     
                  
                  
                     
                        Specific exemption on intermediate use or other specification
                     
                  
               
                     
                        “Dicofol
                     
                  
                  
                     
                        115-32-2
                     
                  
                  
                     
                        204-082-0
                     
                  
                  
                     
                        None”